US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Trillium Therapeutics

18.44

+0.0000

Volume:- -

Turnover:482.19M

Market Cap:1.94B

PE:-34.05

High:18.44

Open:18.44

Low:18.44

Close:18.44

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Trillium Therapeutics

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.trilliumtherapeutics.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. Its include TTI-622, a SIRPa-IgG4 Fc fusion protein that is designed to enhance macrophage-mediated phagocytosis and anti-tumor activity by blocking the CD47, which is in Phase 1 clinical trials; and TTI-621, a SIRPa-IgG1 Fc fusion protein, which is in Phase 1 clinical trials and generates a signal blocking the CD47 for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was incorporated in 2004 is based in Cambridge, Massachusetts.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TRIL/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRIL\",,,,,undefined,":{"symbol":"TRIL","market":"US","secType":"STK","nameCN":"Trillium Therapeutics","latestPrice":18.44,"timestamp":1637096400000,"preClose":18.44,"halted":3,"volume":0,"delay":0,"floatShares":88068209,"shares":104995125,"eps":-0.541566,"marketStatus":"Halted","change":0,"latestTime":"11-16 16:00:00 EST","open":18.44,"high":18.44,"low":18.44,"amount":482193932.59158,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.541566,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":18.44,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRIL\",,,,,undefined,":{"symbol":"TRIL","floatShares":88068209,"roa":"-12.73%","roe":"-21.67%","lyrEps":-0.701478,"shares":104995125,"dividePrice":0,"high":18.44,"amplitude":0,"preClose":18.44,"low":18.44,"week52Low":5.8,"pbRate":"8.51","week52High":20.96,"institutionHeld":0,"latestPrice":18.44,"eps":-0.541566,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.541566,"open":18.44,"prevYearClose":14.71},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.trilliumtherapeutics.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0215},{"period":"1month","weight":-0.0045},{"period":"3month","weight":-0.072},{"period":"6month","weight":-0.022},{"period":"1year","weight":0.1162},{"period":"ytd","weight":-0.0471}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. Its include TTI-622, a SIRPa-IgG4 Fc fusion protein that is designed to enhance macrophage-mediated phagocytosis and anti-tumor activity by blocking the CD47, which is in Phase 1 clinical trials; and TTI-621, a SIRPa-IgG1 Fc fusion protein, which is in Phase 1 clinical trials and generates a signal blocking the CD47 for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was incorporated in 2004 is based in Cambridge, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.399387},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.030441},{"month":3,"riseRate":0.428571,"avgChangeRate":0.038141},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.016441},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.013181},{"month":6,"riseRate":0.428571,"avgChangeRate":0.002046},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.082843},{"month":8,"riseRate":0.714286,"avgChangeRate":0.375355},{"month":9,"riseRate":0.571429,"avgChangeRate":0.04372},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.025004},{"month":11,"riseRate":0.714286,"avgChangeRate":0.135033},{"month":12,"riseRate":0.166667,"avgChangeRate":0.109673}],"exchange":"NASDAQ","name":"Trillium Therapeutics","nameEN":"Trillium Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"TRIL\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRIL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-11-18","symbol":"TRIL","reason":null,"defaultRemindTime":1637245800000,"announcedDate":"2021-11-17","type":"delisting","dateTimestamp":1637211600000},{"market":"US","date":"2021-08-13","symbol":"TRIL","fiscalQuarterEnding":"2021/06","expectedEps":-0.16,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1628827200000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2021-05-07","symbol":"TRIL","fiscalQuarterEnding":"2021/03","expectedEps":-0.18,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1620360000000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2021-03-18","symbol":"TRIL","fiscalQuarterEnding":"2020/12","expectedEps":-0.14,"name":null,"time":"","type":"earning","dateTimestamp":1616040000000,"reportTimeType":"","actualEps":-0.25},{"market":"US","date":"2020-11-16","symbol":"TRIL","fiscalQuarterEnding":"2020/09","expectedEps":-0.14,"name":null,"time":"","type":"earning","dateTimestamp":1605502800000,"reportTimeType":"","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRIL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRIL\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRIL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRIL","date":"2021-11-09","current":-47.117447,"percent":1,"low":-47.88741,"twenty":-47.596535,"median":-47.459653,"eighty":-47.339881,"high":-47.117447,"avg":-47.470347,"sd":0.192193,"marketCap":2313042603},"quantilePoints":[{"date":"2021-10-29","current":-47.331326,"twenty":-47.489596,"median":-47.459653,"eighty":-47.365547,"marketCap":2323542116},{"date":"2021-11-05","current":-47.523817,"twenty":-47.558037,"median":-47.459653,"eighty":-47.365547,"marketCap":2332991677},{"date":"2021-11-09","current":-47.117447,"twenty":-47.596535,"median":-47.459653,"eighty":-47.339881,"marketCap":2313042603}],"updateTime":1746240501723}}}